tiprankstipranks
Cue Biopharma Inc (CUE)
NASDAQ:CUE
US Market
Holding CUE?
Track your performance easily

Cue Biopharma (CUE) Financial Statements

593 Followers

Cue Biopharma Financial Overview

Cue Biopharma's market cap is currently ―. The company's EPS TTM is $-0.906; its P/E ratio is -1.20; Cue Biopharma is scheduled to report earnings on March 12, 2025, and the estimated EPS forecast is $-0.09. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Sep 23Jun 23
Income Statement-
Total Revenue$ 3.34M$ 2.66M$ 1.72M$ 2.10M$ 1.38M
Gross Profit$ 3.34M$ 2.66M$ 1.72M$ 2.10M$ 1.38M
EBIT$ -8.47M$ -9.96M$ -12.11M$ -10.72M$ -12.95M
EBITDA$ -8.36M$ -9.85M$ -12.00M$ -9.86M$ -12.88M
Net Income Common Stockholders$ -8.66M$ -10.17M$ -12.35M$ -11.01M$ -13.19M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 32.42M$ 30.03M$ 41.03M$ 54.69M$ 57.89M
Total Assets$ 44.81M$ 42.33M$ 53.95M$ 68.89M$ 73.16M
Total Debt$ 9.51M$ 11.26M$ 13.00M$ 16.38M$ 18.04M
Net Debt$ -22.91M$ -18.77M$ -28.03M$ -38.31M$ -39.84M
Total Liabilities$ 19.44M$ 20.71M$ 23.91M$ 26.22M$ 27.16M
Stockholders Equity$ 25.37M$ 21.62M$ 30.04M$ 42.67M$ 46.00M
Cash Flow-
Free Cash Flow$ -7.43M$ -10.00M$ -9.84M$ -7.80M$ -10.37M
Operating Cash Flow$ -7.53M$ -9.99M$ -9.78M$ -7.80M$ -10.37M
Investing Cash Flow$ 98.00K$ -10.00K$ -55.00K$ 5.00M$ 5.00M
Financing Cash Flow$ 9.82M$ -1.00M$ 2.35M$ 4.59M$ 2.10M
Currency in USD

Cue Biopharma Earnings and Revenue History

Cue Biopharma Debt to Assets

Cue Biopharma Cash Flow

Cue Biopharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis